More about

Dermatitis

News
October 17, 2023
2 min read
Save

Opzelura effective, well tolerated in children aged at least 2 years with atopic dermatitis

Opzelura effective, well tolerated in children aged at least 2 years with atopic dermatitis

Opzelura achieved significant efficacy for the treatment of atopic dermatitis in children aged as young as 2 years, Incyte announced in a press release.

News
October 13, 2023
2 min read
Save

Amlitelimab shows promise as treatment for moderate to severe atopic dermatitis

Amlitelimab shows promise as treatment for moderate to severe atopic dermatitis

Amlitelimab exhibited clinically meaningful efficacy over 24 weeks in the treatment of adults with moderate to severe atopic dermatitis, according to study results presented at the European Academy of Dermatology and Venereology 2023 Congress.

News
October 13, 2023
2 min read
Save

Phase 3 results show Vtama rapidly reduces itch in children, adults with atopic dermatitis

Phase 3 results show Vtama rapidly reduces itch in children, adults with atopic dermatitis

Dermavant Sciences has announced new “highly favorable” phase 3 pruritus data for Vtama cream for the treatment of moderate to severe atopic dermatitis in adults and children aged as young as 2 years, according to a press release.

News
October 10, 2023
2 min read
Save

Children with AD more likely to patch-test positive for allergic contact dermatitis

Children with AD more likely to patch-test positive for allergic contact dermatitis

Children with vs. without atopic dermatitis are more likely to have positive patch-test reactions for allergic contact dermatitis, according to a study.

News
October 05, 2023
2 min read
Save

Colloidal oatmeal, prescription cream comparable in Black children with atopic dermatitis

Colloidal oatmeal, prescription cream comparable in Black children with atopic dermatitis

Colloidal oatmeal 1%, a natural and affordable cream, is just as effective as prescription barrier cream in the treatment of mild to moderate atopic dermatitis in Black children, according to a study.

News
September 30, 2023
2 min read
Save

Methotrexate shows longer efficacy in pediatric atopic dermatitis than cyclosporine

Methotrexate shows longer efficacy in pediatric atopic dermatitis than cyclosporine

Both methotrexate and cyclosporin are efficacious in the treatment of severe pediatric atopic dermatitis, but methotrexate showed higher rates of sustained treatment response, according to a study.

News
September 26, 2023
1 min read
Save

Arcutis educational campaign addresses unmet patient needs in seborrheic dermatitis

Arcutis educational campaign addresses unmet patient needs in seborrheic dermatitis

Arcutis has launched an educational campaign for people living with seborrheic dermatitis that features expert advice from leading dermatologists and personal stories, according to a company press release.

News
September 20, 2023
1 min read
Save

Roflumilast safe for children aged 2 to 5 years with atopic dermatitis

Roflumilast safe for children aged 2 to 5 years with atopic dermatitis

Roflumilast cream 0.05% achieved positive results in a pediatric trial of a phase 3 program treating children aged 2 to 5 years with mild to moderate atopic dermatitis, according to an Arcutis Biotherapeutics press release.

News
September 18, 2023
1 min read
Save

European Medicines Agency recommends Ebglyss for atopic dermatitis treatment

European Medicines Agency recommends Ebglyss for atopic dermatitis treatment

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the marketing authorization of Ebglyss for atopic dermatitis in patients aged 12 years and older, according to an Almirall press release.

News
September 16, 2023
4 min read
Save

Empowering nurse practitioners, physician associates in clinical atopic dermatitis

Empowering nurse practitioners, physician associates in clinical atopic dermatitis

Atopic dermatitis is an inflammatory skin disease that affects a significant population worldwide. According to the American Academy of Dermatology, it occurs most frequently in children but also impacts as many as 16.5 million adults.

View more